Beyond IgE blocking: Reframing allergen immunotherapy through innate immune regulation

World Allergy Organization Journal·August 6Open Access

Allergy Limited evidence Allergic Disease Review Allergen Immunotherapy

Summary

What was studied

The paper re-examines the mechanisms of allergen immunotherapy (AIT), proposing that innate immune regulation — beyond classical IgE blocking — plays a central role in AIT's therapeutic effects.

Caveats

No sample size, population, comparator, or outcome data could be extracted due to absence of paper content.
Only the paper title, DOI, journal, and publication date were provided — no abstract, methods, results, or conclusions were available. All summary fields have been set to null as no content could be verified from the source text.
Publication date is 2026-08-06, which is in the near future relative to today's date (August 14, 2026) — verify this is a valid published article and not a preprint or ahead-of-print record.

Show all 7

Related Questions

Explore related topics

How does allergen immunotherapy modulate innate immune responses beyond IgE blockade?How does innate immunity contribute to the efficacy of allergen immunotherapy?What role do innate immune cells play in allergen desensitization and tolerance?What mechanisms beyond IgE blockade explain allergen immunotherapy tolerance?How does allergen immunotherapy compare to anti-IgE biologics for long-term tolerance induction?What is the role of innate immune cells like ILCs and dendritic cells in allergy desensitization?

Keep scrolling